Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Recro Pharma Inc. revenue
Recro Pharma Inc.'s revenue is $94.6 million.
What is Recro Pharma Inc.'s revenue?
- Recro Pharma Inc.'s revenue growth from 2015 to 2023 is 82.16%.
- Recro Pharma Inc. has 255 employees, and the revenue per employee ratio is $371,117.
- Recro Pharma Inc.'s peak quarterly revenue was $31.3M in 2019(q2).
- Recro Pharma Inc. peak revenue was $99.2M in 2019.
- Recro Pharma Inc. annual revenue for 2022 was 90.2M, 19.71% growth from 2021.
- Recro Pharma Inc. annual revenue for 2023 was 94.6M, 4.9% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
Recro Pharma Inc. historical revenue
Recro Pharma Inc.'s peak revenue was $99.2M in 2019. The peak quarterly revenue was $31.3M in 2019(q2).
Recro Pharma Inc.'s revenue increased from $52.0m in 2015 to $94.6M currently. That's a 82.16% change in annual revenue.
Recro Pharma Inc. annual revenue
Recro Pharma Inc. annual revenue over time
| Fiscal year / year | Recro Pharma Inc. revenue |
|---|---|
| 2015 | $52.0M |
| 2016 | $69.3M |
| 2017 | $71.8M |
| 2018 | $77.3M |
| 2019 | $99.2M |
| 2020 | $66.5M |
| 2021 | $75.4M |
| 2022 | $90.2M |
| 2023 | $94.6M |
How accurately did Recro Pharma Inc.'s revenue projections match actual performance?
Recro Pharma Inc. annual growth
Recro Pharma Inc. saw the greatest revenue growth in 2016, when revenue increased by 33.46%.
Recro Pharma Inc. had the lowest revenue growth in 2020, when revenue changed by -32.98%.
Recro Pharma Inc. annual growth rate over time
| Year | Recro Pharma Inc. growth |
|---|---|
| 2016 | 33%↑ |
| 2017 | 4%↑ |
| 2018 | 8%↑ |
| 2019 | 28%↑ |
| 2020 | -33%↓ |
| 2021 | 13%↑ |
| 2022 | 20%↑ |
| 2023 | 5%↑ |
Recro Pharma Inc. quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Recro Pharma Inc. quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2015 | - | $18.7M | $16.5M | $16.8M |
| 2016 | $17.7M | $17.3M | $17.0M | $17.4M |
| 2017 | $18.7M | $16.9M | $17.1M | $19.0M |
| 2018 | $19.5M | $21.7M | $18.3M | $17.8M |
| 2019 | $25.1M | $31.3M | $25.3M | $17.6M |
| 2020 | $21.8M | $15.5M | $19.3M | $9.9M |
| 2021 | $16.8M | $18.0M | $18.2M | $22.3M |
| 2022 | $21.2M | $23.2M | $21.6M | $24.3M |
| 2023 | $21.5M | $21.8M | $23.6M | $27.7M |
Recro Pharma Inc. jobs nearby
Do you work at Recro Pharma Inc.?
Is Recro Pharma Inc. transparent about its revenue structure?
Recro Pharma Inc. financial information
| CEO | Gerri Henwood |
| Company Type | Public |
| Employees Number | 255 |
| Date Founded | 2007 |
| Headquarters | Malvern, Pennsylvania |
| Number of Locations | 2 |
| Revenue | $94.6M |
| Net Income | -$19,881,000 |
| Gross Proft | $18.1M (2023) |
| EBITDA | ($2.9M) (2023) |
| PE Ratio | -11.13 |
| Tax Rate | -0.0% |
| Market Capitalization | $147.8M |
| Total Assets | $157,443,000 |
| Ticker | REPH |
Recro Pharma Inc. jobs you might like
Recro Pharma Inc. financing
Recro Pharma Inc. received early financing of $16.0M on 2015-07-13.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $16M | 07/2015 |
| Post Ipo Equity | $40M | 12/2016 |
| Post Ipo Debt | $100M | 11/2017 |
| Post Ipo Debt | $40.5M | 03/2019 |
| Post Ipo Equity | $30M | 05/2021 |
Recro Pharma Inc. investors
| Investors | Security type |
|---|---|
| Broadfin Capital | Post Ipo Equity |
| Athyrium Capital Management LP | Post Ipo Debt |
| Athyrium Capital Management LP | Post Ipo Debt |
Recro Pharma Inc. competitors
Recro Pharma Inc.'s top competitor, Ardelyx, earned an annual revenue of $333.6M.
Recro Pharma Inc.'s smallest competitor is William Stilley with revenue of $200.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Anthera Pharmaceuticals | - | $1.0M | 21 | - |
| William Stilley | - | $200,000 | 2 | - |
| Cardioxyl Pharmaceuticals | - | $1.4M | 30 | - |
| Akebia Therapeutics | - | $160.2M | 324 | - |
| Ardelyx | - | $333.6M | 86 | - |
| Seres Therapeutics | - | $144.9M | 145 | - |
| Chimerix | - | $212,000 | 82 | - |
| Gemini Therapeutics | - | $1.6M | 36 | - |
| Rigel Pharmaceuticals | - | $179.3M | 158 | - |
| Qualitest Pharmaceuticals | - | $230.0M | 7,500 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Recro Pharma Inc. highest paying jobs
Zippia gives an in-depth look into the details of Recro Pharma Inc., including salaries, political affiliations, employee data, and more, in order to inform job seekers about Recro Pharma Inc.. The employee data is based on information from people who have self-reported their past or current employments at Recro Pharma Inc.. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Recro Pharma Inc.. The data presented on this page does not represent the view of Recro Pharma Inc. and its employees or that of Zippia.
Recro Pharma Inc. may also be known as or be related to RECRO PHARMA INC, Recro Pharma, Recro Pharma Inc, Recro Pharma Inc. and Recro Pharma, Inc.